rts logo

Are we looking at the next big move in Pacific Biosciences of California Inc (PACB)?

Pacific Biosciences of California Inc (NASDAQ: PACB) is -65.24% lower on its value in year-to-date trading and has touched a low of $3.45 and a high of $14.55 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PACB stock was last observed hovering at around $3.65 in the last trading session, with the day’s loss setting it -0.24%.

Currently trading at $3.41, the stock is -14.40% and -36.30% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.97 million and changing -6.58% at the moment leaves the stock -61.05% off its SMA200. PACB registered -65.06% loss for a year compared to 6-month loss of -59.16%. The firm has a 50-day simple moving average (SMA 50) of $6.06 and a 200-day simple moving average (SMA200) of -$4.38.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -34.30% gain in the last 1 month and extending the period to 3 months gives it a -65.24%, and is -5.54% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.70% over the week and 9.02% over the month.

Pacific Biosciences of California Inc (PACB) has around 796 employees, a market worth around $913.71M and $200.52M in sales. Profit margin for the company is -152.97%. Distance from 52-week low is -1.30% and -76.56% from its 52-week high. The company has generated returns on investments over the last 12 months (-18.87%).

Pacific Biosciences of California Inc quarterly earnings per share for the current quarter are estimated at -$0.27 with sales reaching $50.39M over the same period.The EPS is expected to grow by 14.46% this year, but quarterly earnings will post 19.10% year-over-year. Quarterly sales are estimated to grow 46.60% in year-over-year returns.

Pacific Biosciences of California Inc (PACB) Top Institutional Holders

378 institutions hold shares in Pacific Biosciences of California Inc (PACB), with institutional investors hold 104.68% of the company’s shares. The shares outstanding are 267.74M, and float is at 251.64M with Short Float at 18.11%. Institutions hold 101.76% of the Float.

The top institutional shareholder in the company is ARK Investment Management, LLC with over 29.82 million shares valued at $249.02 million. The investor’s holdings represent 11.90% of the PACB Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 23.13 million shares valued at $307.59 million to account for 9.23% of the shares outstanding. The other top investors are Blackrock Inc. which holds 20.82 million shares representing 8.31% and valued at over $276.94 million, while Madrone Advisors, LLC holds 6.55% of the shares totaling 16.42 million with a market value of $218.33 million.

Pacific Biosciences of California Inc (PACB) Insider Activity

The most recent transaction is an insider purchase by Meline David W,the company’sDirector. SEC filings show that Meline David W bought 40,000 shares of the company’s common stock on Mar 06 ’24 at a price of $4.40 per share for a total of $0.18 million. Following the purchase, the insider now owns 40000.0 shares.

Pacific Biosciences of California Inc disclosed in a document filed with the SEC on Mar 04 ’24 that HENRY CHRISTIAN Osold a total of 14,177 shares of the company’s common stock. The trade occurred on Mar 04 ’24 and was made at $4.87 per share for $69056.0. Following the transaction, the insider now directly holds 2.6 million shares of the PACB stock.

Still, SEC filings show that on Mar 04 ’24, Van Oene Mark () disposed off 9,186 shares at an average price of $4.87 for $44745.0. The insider now directly holds 1,668,826 shares of Pacific Biosciences of California Inc (PACB).

Related Posts